These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 22371139)

  • 21. Delayed-onset heparin-induced thrombocytopenia and cerebral thrombosis after a single administration of unfractionated heparin.
    Warkentin TE; Bernstein RA
    N Engl J Med; 2003 Mar; 348(11):1067-9. PubMed ID: 12637624
    [No Abstract]   [Full Text] [Related]  

  • 22. Delayed-onset heparin-induced thrombocytopenia and thrombosis.
    Ann Intern Med; 2001 Oct; 135(7):S-45. PubMed ID: 11596575
    [No Abstract]   [Full Text] [Related]  

  • 23. Fondaparinux thromboprophylaxis-associated heparin-induced thrombocytopenia syndrome complicated by arterial thrombotic stroke.
    Salem M; Elrefai S; Shrit MA; Warkentin TE
    Thromb Haemost; 2010 Nov; 104(5):1071-2. PubMed ID: 20806120
    [No Abstract]   [Full Text] [Related]  

  • 24. Heparin-induced thrombocytopenia: diagnosis and management.
    Liebman HA
    Vascular; 2008; 16 Suppl 1():S71-6. PubMed ID: 18544310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. eComment: Heparin-induced thrombocytopenia.
    Bockeria L; Samsonova N; Klimovich L
    Interact Cardiovasc Thorac Surg; 2009 Dec; 9(6):1025. PubMed ID: 19919964
    [No Abstract]   [Full Text] [Related]  

  • 26. Heparin-Induced Thrombocytopenia and Cardiac Surgery.
    Solanki J; Shenoy S; Downs E; Palkimas S; Goldman S; Sharma AM
    Semin Thorac Cardiovasc Surg; 2019 Autumn; 31(3):335-344. PubMed ID: 30448485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical sample investigation (CSI) hematology: pinpointing the precise onset of heparin-induced thrombocytopenia (HIT).
    Warkentin TE; Sheppard JI
    J Thromb Haemost; 2007 Mar; 5(3):636-7. PubMed ID: 17155944
    [No Abstract]   [Full Text] [Related]  

  • 28. Impact of heparin-induced thrombocytopenia on postoperative outcomes after cardiac surgery.
    Kerendi F; Thourani VH; Puskas JD; Kilgo PD; Osgood M; Guyton RA; Lattouf OM
    Ann Thorac Surg; 2007 Nov; 84(5):1548-53; discussion 1554-5. PubMed ID: 17954061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ten-year screening for thrombocytopenia after aortic valve replacement.
    Sun X; Hill PC; Ellis J; Corso PJ; Taylor-Panek SL; Chen F
    Interact Cardiovasc Thorac Surg; 2014 May; 18(5):562-7. PubMed ID: 24497605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet count recovery and seroreversion in immune HIT despite continuation of heparin: further observations and literature review.
    Shih AW; Sheppard JI; Warkentin TE
    Thromb Haemost; 2017 Oct; 117(10):1868-1874. PubMed ID: 28837208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heparin/PF4 antibodies formation after heparin treatment: temporal aspects and long-term follow-up.
    Mattioli AV; Bonetti L; Zennaro M; Ambrosio G; Mattioli G
    Am Heart J; 2009 Mar; 157(3):589-95. PubMed ID: 19249435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Laboratory testing for heparin-induced thrombocytopenia: a conceptual framework and implications for diagnosis.
    Warkentin TE; Greinacher A; Gruel Y; Aster RH; Chong BH;
    J Thromb Haemost; 2011 Dec; 9(12):2498-500. PubMed ID: 22947414
    [No Abstract]   [Full Text] [Related]  

  • 33. Evaluation of a new automated panel of assays for the detection of anti-PF4/heparin antibodies in patients suspected of having heparin-induced thrombocytopenia.
    Legnani C; Cini M; Pili C; Boggian O; Frascaro M; Palareti G
    Thromb Haemost; 2010 Aug; 104(2):402-9. PubMed ID: 20539902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fondaparinux-related thrombocytopenia in a patient with former HIT. Response to Rota et al. (Thromb Haemost 2008; 99: 779-781).
    Schindewolf M; Lindhoff-Last E
    Thromb Haemost; 2008 Jul; 100(1):168-9; author reply 169-70. PubMed ID: 18612559
    [No Abstract]   [Full Text] [Related]  

  • 35. Temporal aspects of anti-heparin-PF4 antibodies in heparin-induced thrombocytopenia.
    Newall F; Ignjatovic V; Monagle P
    Ann Thorac Surg; 2006 May; 81(5):1944; author reply 1944-5. PubMed ID: 16631722
    [No Abstract]   [Full Text] [Related]  

  • 36. Detection and significance of heparin-platelet factor 4 antibodies.
    Francis JL
    Semin Hematol; 2005 Jul; 42(3 Suppl 3):S9-14. PubMed ID: 16105558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence and clinical relevance of anti-platelet factor 4/heparin antibodies before cardiac surgery.
    Selleng S; Malowsky B; Itterman T; Bagemühl J; Wessel A; Wollert HG; Warkentin TE; Greinacher A
    Am Heart J; 2010 Aug; 160(2):362-9. PubMed ID: 20691844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The incidence and implications of anti-heparin-platelet factor 4 antibody formation in a pediatric cardiac surgical population.
    Mullen MP; Wessel DL; Thomas KC; Gauvreau K; Neufeld EJ; McGowan FX; Dinardo JA
    Anesth Analg; 2008 Aug; 107(2):371-8. PubMed ID: 18633010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypothermic cardiopulmonary bypass as a determinant of late thrombocytopenia following cardiac operations in pediatric patients.
    Ranucci M; Carlucci C; Isgrò G; Brozzi S; Boncilli A; Costa E; Frigiola A
    Acta Anaesthesiol Scand; 2009 Sep; 53(8):1060-7. PubMed ID: 19496765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heparin-induced thrombocytopenia in patients receiving mechanical circulatory support.
    Schenk S; El-Banayosy A; Prohaska W; Arusoglu L; Morshuis M; Koester-Eiserfunke W; Kizner L; Murray E; Eichler P; Koerfer R; Greinacher A
    J Thorac Cardiovasc Surg; 2006 Jun; 131(6):1373-81.e4. PubMed ID: 16733172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.